L-carnitine is a popular dietary supplement among athletes
In addition, the GLP-1 agonists may make some drugs more aversive or unpleasant, says Luba Yammine, an associate professor of psychiatry at UTHealth Houston who is currently the principal investigator of a clinical trial evaluating a GLP-1 agonist as a potential treatment for smoking cessation and post-cessation weight management
The TRIUMPH program includes seven other Phase 3 trials (TRIUMPH-1 general obesity 80 weeks, TRIUMPH-2 obesity+T2D, TRIUMPH-3 obesity+CV disease, plus T2D, OSA, and CVOT) with readouts expected during 2026
Winslet M, Tejan J: Subungual amelanotic melanoma: a diagnostic pitfall
Safety, Efficacy, and Personalized Care: Our PlexusDx Commitment Embarking on any weight loss journey, especially one involving prescription medications, requires a steadfast commitment to safety, efficacy, and individualized care